New Drug Alert: Revolutionary Pill Promises to Eliminate CPAP Machines for Sleep Apnea sufferers
Sedalia, Missouri – A groundbreaking new drug developed by Apnimed, a Massachusetts-based company, shows promise in revolutionizing the treatment of sleep apnea, a condition affecting around 39 million Americans, including President Biden. The innovative drug, known as AD109, aims to provide a more convenient and potentially more effective alternative to CPAP machines, which are currently the most common treatment for obstructive sleep apnea (OSA). CPAP machines work by delivering continuous positive airway pressure to keep …